WENDY HENDERSON: Open Payments
NPI 1407232689 · CROSSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 25 payments from 10 companies in 2025. Trend: 2023 $327 · 2024 $345 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $201 |
| Neurocrine BioSciences, Inc. | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
Products named: VRAYLAR, INGREZZA, AIRSUPRA, AUSTEDO XR, ABILIFY ASIMTUFII, The Cologuard Plus Collection Kit, Ozempic, MOUNJARO.
Industry payments across TN — which companies pay providers there.
